- Gastroenterology Education and CPD for trainees and specialists - https://www.gastrotraining.com -
AASLD: Anti-HCV Drug Boosts Response Rates (CME/CE)
BOSTON (MedPage Today) — Combining the direct anti-viral agent telaprevir with standard hepatitis C care can sharply improve response rates and shorten the treatment period, researchers reported.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com